Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the efficacy of silodosin 4 and 8 mg once daily with
placebo in the treatment of subjects with moderate to severe abacterial chronic
prostatitis/chronic pelvic pain syndrome during a 12 week treatment period. The secondary
objective is to compare the safety of silodosin 4 and 8 mg once daily with placebo.